Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation. (Q48230061)
Jump to navigation
Jump to search
scientific article published on 16 August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation. |
scientific article published on 16 August 2014 |
Statements
1 reference
Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation. (English)
1 reference
Edward A Stadtmauer
1 reference
César O Freytes
1 reference
Juan J Toro
1 reference
Rosa F Yeh
1 reference
Voravit Ratanatharathorn
1 reference
Görgün Akpek
1 reference
Entezam Sahovic
1 reference
Guido J Tricot
1 reference
Paul J Shaughnessy
1 reference
Darrell J White
1 reference
Tulio E Rodriguez
1 reference
Scott R Solomon
1 reference
Louie H Yu
1 reference
Cathy Zhao
1 reference
Shiva Patil
1 reference
Elizabeth Armstrong
1 reference
Angela Smith
1 reference
Agnes Elekes
1 reference
Kazunobu Kato
1 reference
Donna E Reece
1 reference
16 August 2014
1 reference
20
1 reference
1949-1957
1 reference
12
1 reference
Identifiers
1 reference
1 reference